Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.

Infection with the Group A Streptococcus (GAS) can result in immune mediated brain disease characterised by a spectrum of movement and psychiatric disorders. We have previously described anti-neuronal antibodies in patients that bind to a restricted group of brain antigens with molecular weights 40...

Full description

Bibliographic Details
Main Authors: Dale, R, Candler, P, Church, A, Wait, R, Pocock, J, Giovannoni, G
Format: Journal article
Language:English
Published: 2006
_version_ 1797060695516250112
author Dale, R
Candler, P
Church, A
Wait, R
Pocock, J
Giovannoni, G
author_facet Dale, R
Candler, P
Church, A
Wait, R
Pocock, J
Giovannoni, G
author_sort Dale, R
collection OXFORD
description Infection with the Group A Streptococcus (GAS) can result in immune mediated brain disease characterised by a spectrum of movement and psychiatric disorders. We have previously described anti-neuronal antibodies in patients that bind to a restricted group of brain antigens with molecular weights 40 kDa, 45 kDa (doublet) and 60 kDa. The aim of this study was to define these antigens using 2-dimensional electrophoresis or ion exchange and hydrophobic interaction chromatography, followed by mass spectrometry. The findings were confirmed using commercial antibodies, commercial antigens and recombinant human antigens. The autoantigens were neuronal glycolytic enzymes--NGE (pyruvate kinase M1, aldolase C, neuronal-specific and non-neuronal enolase). These are multifunctional proteins that are all expressed intracellularly and on the neuronal cell surface. On the neuronal plasma membrane, NGE are involved in energy metabolism, cell signalling and synaptic neurotransmission. Anti-NGE antibodies were more common in the 20 unselected post-streptococcal CNS patients compared to 20 controls. In vitro experiments using cultured neurons showed that commercial anti-NGE antibodies induced apoptosis compared to blank incubation and control anti-HuD antibody. GAS also expresses glycolytic enzymes on cell surfaces that have 0-49% identity with human NGE, suggesting molecular mimicry and autoimmune cross-reactivity may be the pathogenic mechanism in post-streptococcal CNS disease.
first_indexed 2024-03-06T20:20:45Z
format Journal article
id oxford-uuid:2db2ae2b-2fd4-43f5-9b13-d29e9a349cec
institution University of Oxford
language English
last_indexed 2024-03-06T20:20:45Z
publishDate 2006
record_format dspace
spelling oxford-uuid:2db2ae2b-2fd4-43f5-9b13-d29e9a349cec2022-03-26T12:44:39ZNeuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:2db2ae2b-2fd4-43f5-9b13-d29e9a349cecEnglishSymplectic Elements at Oxford2006Dale, RCandler, PChurch, AWait, RPocock, JGiovannoni, GInfection with the Group A Streptococcus (GAS) can result in immune mediated brain disease characterised by a spectrum of movement and psychiatric disorders. We have previously described anti-neuronal antibodies in patients that bind to a restricted group of brain antigens with molecular weights 40 kDa, 45 kDa (doublet) and 60 kDa. The aim of this study was to define these antigens using 2-dimensional electrophoresis or ion exchange and hydrophobic interaction chromatography, followed by mass spectrometry. The findings were confirmed using commercial antibodies, commercial antigens and recombinant human antigens. The autoantigens were neuronal glycolytic enzymes--NGE (pyruvate kinase M1, aldolase C, neuronal-specific and non-neuronal enolase). These are multifunctional proteins that are all expressed intracellularly and on the neuronal cell surface. On the neuronal plasma membrane, NGE are involved in energy metabolism, cell signalling and synaptic neurotransmission. Anti-NGE antibodies were more common in the 20 unselected post-streptococcal CNS patients compared to 20 controls. In vitro experiments using cultured neurons showed that commercial anti-NGE antibodies induced apoptosis compared to blank incubation and control anti-HuD antibody. GAS also expresses glycolytic enzymes on cell surfaces that have 0-49% identity with human NGE, suggesting molecular mimicry and autoimmune cross-reactivity may be the pathogenic mechanism in post-streptococcal CNS disease.
spellingShingle Dale, R
Candler, P
Church, A
Wait, R
Pocock, J
Giovannoni, G
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title_full Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title_fullStr Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title_full_unstemmed Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title_short Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
title_sort neuronal surface glycolytic enzymes are autoantigen targets in post streptococcal autoimmune cns disease
work_keys_str_mv AT daler neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease
AT candlerp neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease
AT churcha neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease
AT waitr neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease
AT pocockj neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease
AT giovannonig neuronalsurfaceglycolyticenzymesareautoantigentargetsinpoststreptococcalautoimmunecnsdisease